Global Blood Testing Devices Market Professional Survey Report 2019
Blood testing is crucial for the diagnosis of various chronic diseases such as cancer, HIV/AIDS, diabetes, anemia and coronary heart disease. It is one the routine examinations and does not require special preparation. There are various types of blood test recommended by the healthcare provider to analyze the components of blood and determine the presence of diseases. Glucose test, creatinine test, coagulation test and full blood count are common blood tests done in hospitals and diagnostic centers.
The blood testing devices market is expected to grow significantly in the coming years, owing to the key factors such as increasing demand for portable and handled blood testing devices and growing demand of diagnostic testing. Other factors governing the growth of the market are increasing number of patients with chronic disease such as diabetes, kidney diseases and other. Additionally, integration of software application with blood testing devices will enhance the growth opportunities in the blood testing devices market.
North America holds the largest share in the blood testing devices market with US being the largest contributor to the market growth. In North America, new product launches by key players and availability of various types of technologically advanced analyzer and other instruments are the key factors driving the growth of the market. In Asia Pacific, the market is expected to exhibit potential growth due to rising emphasis on early diagnosis of disease and growing awareness about point-of-care testing blood testing. India, Japan and China are expected to be the major countries contributing to the growth of the market due to developing healthcare sector, huge demand for diagnostic services and rising prevalence of diseases.
The global Blood Testing Devices market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Blood Testing Devices volume and value at global level, regional level and company level. From a global perspective, this report represents overall Blood Testing Devices market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Blood Testing Devices in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Blood Testing Devices manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Abbott
Bio-Rad
Roche
Thermo Fisher Scientific
Siemens
Trinity Biotech
BioMerieux
Luminex
Getein Biotech
Goldsite Diagnostics
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Bench-Top
Portable
Segment by Application
Hospitals
Clinics
Diagnostic Centers
Home Care
Others
The blood testing devices market is expected to grow significantly in the coming years, owing to the key factors such as increasing demand for portable and handled blood testing devices and growing demand of diagnostic testing. Other factors governing the growth of the market are increasing number of patients with chronic disease such as diabetes, kidney diseases and other. Additionally, integration of software application with blood testing devices will enhance the growth opportunities in the blood testing devices market.
North America holds the largest share in the blood testing devices market with US being the largest contributor to the market growth. In North America, new product launches by key players and availability of various types of technologically advanced analyzer and other instruments are the key factors driving the growth of the market. In Asia Pacific, the market is expected to exhibit potential growth due to rising emphasis on early diagnosis of disease and growing awareness about point-of-care testing blood testing. India, Japan and China are expected to be the major countries contributing to the growth of the market due to developing healthcare sector, huge demand for diagnostic services and rising prevalence of diseases.
The global Blood Testing Devices market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Blood Testing Devices volume and value at global level, regional level and company level. From a global perspective, this report represents overall Blood Testing Devices market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Blood Testing Devices in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Blood Testing Devices manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Abbott
Bio-Rad
Roche
Thermo Fisher Scientific
Siemens
Trinity Biotech
BioMerieux
Luminex
Getein Biotech
Goldsite Diagnostics
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Bench-Top
Portable
Segment by Application
Hospitals
Clinics
Diagnostic Centers
Home Care
Others
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
